Filing Details
- Accession Number:
- 0001104659-15-013088
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-23 17:09:59
- Reporting Period:
- 2015-02-19
- Filing Date:
- 2015-02-23
- Accepted Time:
- 2015-02-23 17:09:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1446847 | Ironwood Pharmaceuticals Inc | IRWD | Pharmaceutical Preparations (2834) | 043404176 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1024003 | Jr C Joseph Cook | C/O Ironwood Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2015-02-19 | 32,900 | $15.60 | 49,175 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2015-02-20 | 2,600 | $15.63 | 46,575 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Class B Common Stock | 306,163 | Direct | |
| Class B Common Stock | 24,000 | Indirect | By Farview Management Company, L.P. |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.44 to $15.78, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.55 to $15.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The reporting person is a general partner of Farview Management Company, L.P., the beneficial owner of the securities.
Billionaire Hedge Funds
